Quadria Capital has made an investment of ₹850 crores into the share capital of Nephrocare Health Services Private Limited to acquire a significant minority stake through a combination of a primary investment and the purchase of shares from existing shareholders.

Khaitan & Co advised Quadria Capital on this investment deal.

The core team consisted of Bharat Anand (Partner), Srikant C.V. (Partner), Mukul Aggarwal (Counsel), Shraddha Desai (Principal Associate) and Siddhartha Das (Senior Associate) with assistance from the following:

Due Diligence: Nirupam Lodha (Partner), Mukul Aggarwal (Counsel), Akriti Shashni (Senior Associate), Malika Nandkeolyar (Senior Associate), Zeni Arora (Senior Associate), Shreshth Singh Tomar (Associate) and Shreya Mishra (Associate);

Competition law aspects: Pranjal Prateek (Partner) and Nilav Banerjee (Senior Associate).

Khaitan & Co Bengaluru team led by Sanjay Khan Nagra (Partner) and BN Vivek (Partner) represented Bessemer Venture Partner.

Anagram Partners acted as the legal advisors to Investcorp on its partial exit from NephroPlus as a part of this investment deal.

The transaction team consisted of Simone Reis (Partner), Shwetank Chaubey (Principal Associate), Sarthak Parnami (Senior Associate) and Rishabh Chhabaria (Associate).

Quadria is one of Asia’s largest healthcare-focused Private Equity firm with assets under management of over US$ 3.4 billion. It invests in the high-growth healthcare sector of some of the world’s fastest-growing economies in South Asia and Southeast Asia including Healthcare Delivery, Life Sciences, Medical Technology and Associated Healthcare Services subsectors.

Nephrocare Health Services Private Limited is Asia’s largest dialysis network with around 450 dialysis centers.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.